Neuroenhancement: status quo and perspectives
- 1.2k Downloads
Neuroenhancement is a pharmacological attempt to increase cognitive performance in healthy humans. Strategies to improve learning and memory aim at plasticity pathways in the brain; phosphodiesterase inhibitors such as rolipram and NMDA-modulating drugs like donepezil and d-cycloserine have been tested in clinical trials. Modafinil and methylphenidate are used to increase attention and vigilance. Other fields of intense research include mood, social interaction and sexual performance. So far, all clinical trials of neuroenhancing drugs have either failed or demonstrated only very limited efficacy. However, the high demand for neuroenhancement and the intense research efforts might come up with more efficacious drugs in the near future implying the need for an extended ethical discussion in society.
Keywordsneuroenhancement plasticity learning cognition modafinil
Conflict of interest statement
The authors declare no competing financial interests.
- 4.Cavanaugh JC, Blanchard-Fields F (2006) Adult development and aging. Wadsworth Publishing/Thomson Learning, BelmontGoogle Scholar
- 8.Gasser P (1996) Die psycholytische Psychotherapie in der Schweiz von 1988–1993. Schweizer Archiv für Neurologie und Psychiatrie 147:56–65Google Scholar
- 10.Hebb DO (1949) The organization of behavior; a neuropsychological theory. Wiley, New YorkGoogle Scholar